XERS (STOCKS)
Xeris Biopharma Holdings, Inc. Common Stock
$6.890000
-0.330000 (-4.57%)
Prev close: $7.220000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John Patrick Shannon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,180.03M
- Employees
- 394
- P/E (TTM)
- -66.83
- P/B (TTM)
- -1,328.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $33.38M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $11.45M |
| Costs And Expenses | $108.99M |
| Gross Profit | $22.27M |
| Operating Expenses | $97.89M |
| Selling, General, and Administrative Expenses | $79.49M |
| Research and Development | $18.40M |
| Operating Income/Loss | -$75.61M |
| Income/Loss From Continuing Operations After Tax | -$83.78M |
| Income/Loss From Continuing Operations Before Tax | $6.92M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $1.32M |
| Net Income/Loss | -$83.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$83.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$83.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $151.50M |
| Current Assets | $144.59M |
| Inventory | $12.30M |
| Prepaid Expenses | $4.01M |
| Other Current Assets | $128.28M |
| Noncurrent Assets | $6.91M |
| Fixed Assets | $6.70M |
| Other Non-current Assets | $211.00K |
| Liabilities | $131.61M |
| Current Liabilities | $35.46M |
| Accounts Payable | $5.19M |
| Wages | $8.40M |
| Other Current Liabilities | $21.88M |
| Noncurrent Liabilities | $96.14M |
| Long-term Debt | $87.48M |
| Other Non-current Liabilities | $8.67M |
| Equity | $19.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $19.89M |
| Liabilities And Equity | $151.50M |
| Net Cash Flow From Operating Activities | -$71.83M |
| Net Cash Flow From Operating Activities, Continuing | -$71.83M |
| Net Cash Flow From Investing Activities | -$10.57M |
| Net Cash Flow From Investing Activities, Continuing | -$10.57M |
| Net Cash Flow From Financing Activities | $43.51M |
| Net Cash Flow From Financing Activities, Continuing | $43.51M |
| Exchange Gains/Losses | $24.00K |
| Net Cash Flow | -$38.87M |
| Net Cash Flow, Continuing | -$38.89M |
| Comprehensive Income/Loss | $7.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $7.17M |
| Other Comprehensive Income/Loss | -$38.04M |